| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.33 M USD | -12.53 M USD | -8.78 M USD | -5.25 M USD | -1.83 M USD | -657299 USD | -495798 USD | -512806 USD | -543520 USD | -314182 USD | -867644 USD | -538595 USD |
| Depreciation & Amortization | 332070 USD | 223527 USD | 149147 USD | 25163 USD | 12741 USD | 14066 USD | 13774 USD | 49361 USD | 6629 USD | 60731 USD | 4251 USD | 0 USD |
| Stock-Based Compensation | — | — | — | — | — | 271930 USD | 277252 USD | 755215 USD | 520271 USD | 702300 USD | 116500 USD | 1.26 M USD |
| Capital Expenditures | 174491 USD | 1.66 M USD | 82251 USD | 193982 USD | 0 USD | 1191 USD | 860 USD | 18850 USD | 3718 USD | 3439 USD | 4793 USD | 0 USD |
| Cash Flow from Investing | -836306 USD | -2.32 M USD | -656150 USD | -14.62 M USD | 0 USD | -1191 USD | -15276 USD | -13908 USD | -84008 USD | -3439 USD | -623603 USD | 0 USD |
| Cash Flow from Financing | 4.75 M USD | 9.29 M USD | 3.43 M USD | 39.47 M USD | 2.90 M USD | 1.61 M USD | 442255 USD | 527640 USD | 670705 USD | 324622 USD | 1.40 M USD | 650778 USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 0 USD | 3.14 M USD | 541143 USD | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | -5.51 M USD | -14.19 M USD | -8.86 M USD | -5.44 M USD | -1.83 M USD | -658490 USD | -496658 USD | -531656 USD | -547238 USD | -317621 USD | -872437 USD | -538595 USD |
Sunshine Biopharma Inc. is a pharmaceutical company focused on the research, development, commercialization, and distribution of medicines across oncology, antivirals, and other therapeutic areas. Through its commercial operations, the company markets generic prescription drugs in Canada, including treatments used for cholesterol management, bacterial infections, and nausea relief, primarily through its Nora Pharma subsidiary. Sunshine Biopharma also works on biosimilar products and preclinical drug candidates aimed at cancer and viral diseases, supporting a portfolio that spans approved medicines and experimental programs. In addition to prescription pharmaceuticals, the company is involved in science-based nutritional supplements, giving it a broader presence in the healthcare market. Sunshine Biopharma Inc. plays a role in supplying affordable therapeutic options and advancing drug development in regulated pharmaceutical markets.